Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Adverse reactions and other safety information such as pregnancy, abuse, misuse, medication errors, overdose, off-label use or lack of effect related to Gilead products may be reported directly to Gilead at Safety_FC@gilead.com or via the Medical Information team on firstname.lastname@example.org. You can also report adverse reactions via the national reporting scheme.
This website is funded by Gilead Sciences.
200/IHQ/15-09//1011i Date of preparation: August 2016